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Summary: When a constant dose of digoxin was administered orally over several days, the digoxin concen-
tration in saliva and erythrocytes rose faster than in serum. Thus, the saliva/serum concentration ratio was
below 1.0 after a single dose and above 1.0 in the steady state.
The digoxin concentration was relatively high in "unstimulated" (more or less spontaneous) saliva and
decreased with Stimulation of the salivary flow rate. It therefore appeared that the actual salivary digoxin
concentration depended on 2 components: the digoxin concentration in "stimulated" saliva depended only
on the rapid diffusion from the blood into saliva, and the concentration in the "unstimulated" saliva depended
on the rapid diffusion and on a slower exchange with the intracellular compartment. It is suggested that
unstimulated saliva reflects the intracellular digoxin concentration and stimulated saliva reflects the free
digoxin concentration of the serum.
Both effects must be taken in account when interpreting the saliva/serum ratio, and they may explain
conflicting results in the literature.
Introduction
Saliva has been recommended for therapeutic drug
monitoring becäuse it is more cönVenient for sämpling
than blood (l, 2), Several authors have studied the
use of saliva to measure the digoxin concentration
and found a good or everi excellent correlation be-
tween the cöncentrations in saliva and those in plasma
or serum (tab. 1). Danhof & Breimer (11), however,
expressed doubts on the use of saliva for digoxin
monitoring, in view of the substantial Variation of the
saliva/pläsrna ratio reported by Joubert et al. (12).
In the following we report on 2 phenomena which
lead to intraindividual variability of the saliVa/sef ürri
concentration ratio of digoxin. If they are cpmpletely
understood they could provide additional useful in-
formation for the surveillance of patients on digoxin
therapy.
Materials and Methode
Materials
Digoxin controls (cat. No. 9511^10) were purchased from Ab-
bott Diagnostics (GmbH (D-6200 Wiesbaden), Therapeutic
Drug Monitoring Control level l and 2 (cat. No. C 455-5) from
Biorad (D-8000 München 50) and sodium metrizoate-Ficoll
(Lymphoprep, cat. No. 350031, density 1.077) from Novo In-
dustry Pharmazeutika (D-6500 Mainz).
Methods
Digoxin was determined with a TDx analyser (Abbott GmbH)
following the manufacturer's instructions. The imprecision and
recovery of the digoxin determination in control sera is reported
in table 2. Furthermore 6 calibrators which are usually supph'ed
with the reagent kit from Abbott were diluted 1 + 1 with pool
serum and saliva. Identical results were obtained, indicating
that the same procedure could be used for both specimens.
The free fraction of digoxin was determined in ultrafiltrates
which were obtained from venous blood with the centrifree™
micropartition System from Amicon GmbH (cat. No. 4104, -
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5810 Witten). The ultrafilters were washed twice with distilied
water and dried prior to use to improve the imprecision from
filter to filter. The pH-value was adjusted in serum samples to
7.4 with 0.1 mol/1 HC1. The centrifugation was performed at
1000 g for 20 minutes at 37 °C.
Saliva samples (13) were obtained with salivettes (W. Sarstedt,
D-5223 N mbrecht, catalogue No. 51.1534.001). Unstimulated
saliva was obtained by placing the cotton roll of a salivette into
the buccal or sublingual cavity, and left in this position for 4
minutes to become sufilcientiy soaked with saliva. Sufficient
stimulated saliva was obtained by chewing on the cotton roll
for about 30 seconds. When this sampling procedure was re-
peated several tirnes, a break of 15 seconds was inchided be-
tween each roll.
The concentration of digoxin in erythrocytes was determined
according to Gorodischer et al. (4) with some modifications: 20
ml heparinised venous blood were diluted with 20 ml 0.85 g/l
NaCl and then passed through a Lymphoprep solution (30 min,
1800 min"1, 20 °C). The supernatant was decanted and the
pellet (after counting the number of erythrocytes) frozen for at
least 2 hours. The thawed concentrate was subjected to ultra-
Tab. 1. Saliva/serum concentration ratios of digoxin reported
in the literature.
Mean Number of probands Correlation Refer-
saliva/serum \ \ coefficient ence
ratio
1.14± 0.48
0.78 ± 0.07
1.34 ±0.44
1.68b)
0.62
0.66 ± 0.20
0.67 ± 0.10
1.25 ± 0.41
34 patients,
steady-state
18 patients,
steady state
4 healthy persons,
steady-state
20 patients,
steady-state
14 patients,
single dose
12 patients,
steady-state
50 patients,
steady-state
12 healthy persons,
single dose
0.97
0.99
0.63-0.883)
0.90
0.58
0.71
0.96
0.90
3
4
5
6
7
8
9
10
sonic treatment twice for 15 minutes at room temperature, with
mixing between the 2 time periods. The haemolysate was now
diluted l + l with distilied water and centrifuged (30 min,
10000g). The supernatant was used for digoxin analysis (CH).
The digoxin concentration of single erythrocytes was calculated
from the digoxin concentration of the diluted haemolysate CH
(Mg ·Γι): _2 CH
VE represents volume of the single erythrocyte (fl) and E the
number of erythrocytes per litre of blood concentrate.
Alternatively, digoxin was determined in the blood cell com-
partment. The Lymphoprep and freezing Steps were then omit-
ted from the procedere described b ve. The digoxin concen-
tration CBC was calculated aceording to Vermeij (15):
CBC =
- HK)
HK
CB and cp represent the digoxin concentration in venous blood
and plasma, res.pectively, and HK is the haematocrit fraction
(100% = 1.0). The digoxin eoncentrations in the blood cell
compartment were slightly higher than those in single eryth-
rocytes. However, both valiies correlated well with each other
(fig. 1). Therefore, in the following only results from the first
procedure are reported.
^r 1.60
σο
Ι 1.20
0.80
.g 0.40
o
a) Correlation coefficients for individual subjects
b) Plasma concentration
Ο ΟΛΟ 0.80 1.20 1.60
Digoxin in erythrocytes [jug-Γ1]
Fig. 1. The digoxin concentration in erythrocytes (calculated
according to Gorodischer et al. (14)) and in the blood
cell compartment (calculated according to Vermeij (15)).
Standardised principal component analysis: y = 1.04 χ
4- 0.10 (n = 17); coefficient of Correlation r = 0.86.
Tab. 2. Imprecision of the digoxin determination with a TDx analytical System.
Material Assigned
value
Range Mean
vahie
Standard
deviation
CV
Imprecision within series
Digoxin controls, low
middle
high
Between-days imprecision
Digoxin control, middle
Therapeutic drug
monitoring control
Level l
Level 2
0.75
1.50
3.50
1.50
0.71
1.72
0.55-0.95
1.30-1.70
3.15-3.85
1.30-1.70
0.57-0.85
1.37-2.19
0.68
1.47
3.56
1.49
0.71
1.45
0.06
0.07
0.13
0.07
0.07
0.09
8.8
4.7
3.6
4.7
9.8
6.2
10
10
10
30
30
30
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Digoxin (Lanicor® tablels from Boehringer Mannheim Corp.)
was administered orally to 6 nien (23 — 50 years) and one women
(48 years), who were not aware of any disease and followed
their usual Professional lives.
Fitting lines were calculated by standardised principle compo-
nent analysis (16). The study was accepted by the local com-
mission on medical ethics.
Resuits
The use of salivettes means that saliva sampling was
standardised to some extent (13). With appropriate
sampling times (between 15 seconds and several min-
utes) the salivary flow rate can be estimated from the
saliva taken up by the dental cotton roll of the sal-
ivette during a defined time. Using this technique it
was found that the salivary flow rate increased more
than fourfold after Stimulation by chewing. In figure
2, a representative example is shown which had been
repeated 5 times. The sublingual flow rate was always
higher than the buccal flow rate. This particular find-
ing was not observed in 3 other probands.
The digoxin concentration was highest in unstimu-
lated saliva, it declined with continuation of the saliva
flow and reached a plateau level after a few minutes.
When the Stimulation by chewing was interrupted,
the digoxin concentration rose again (flg. 2). There-
fore, the digoxin concentration in unstimulated saliva
appears to have 2 components: one is independent of
the flow rate and is readily transferred into saliva
(plateau level); the other depends on the flow rate, is
much slower and is exhausted very soon after the flow
rate is stimulated. Because of this effect, the saliva/
serum concentration ratio (CSA/CS) differs for unsti-
mulated and stimulated saliva.
The total digoxin concentration in serum was close
to the concentration in unstimulated saliva, whereas
the free serum concentration was only slighlty higher
than the "plateau level" in stimulated saliva.
The salivary osmolality was surprisingly constant dur-
ing the whole experiment, although slight fluctuations
in unstimulated saliva were always observed in close
parallelism with the digoxin and sodium concentra-
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Fig. 2. The salivary digoxin concentration before and during continuous Stimulation by chewing on cotton rolls of 22 salivettes
during 37 minutes. The first 6 and iid last 6 colunins (saliv ry flow rate) represent unstimulated (b buccal and s sublingual)
saliva and the cplumns between represent flow rates stimulated by ehewing. All samples were taken consecutively with a
20 minutes break between the 16* and 17Λ sample. The male, healthy proband (50 years) took 0.5 mg digoxin at 15 days
and the last dose 7 hours prior to sampling.
o-« k+,
n- -D Na+,
χ—χ osmolality,
•—· salivary digoxin,
A total digoxin in serum,
Δ free (unbound) digoxin in serum.
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tion. In stimulated saliva, however, the digoxin and
sodium concentration behaved inversely. The potas-
sium concentration showed less Variation.
In further experiments, "plateau levels" were taken
äs the mean value from several plateau concentrations
and used äs the digoxin concentration in stimulated
saliva.
In the next experiment the digoxin concentrations in
stimulated (CSSA) and unstimulated (CSA) saliva were
compared with the total digoxin concentration in
serum and erythrocytes, and with the protein-un-
bound concentration in sera from 7 probands (fig. 3).
The saliva/serum concentration ratio of digoxin
(CSSA/CS) was 0.69 after a single dose. This value was
close to the one reported by Mahmod et al. (9), and
it decreased to 0.53 in the steady state. The digoxin
concentration in the erythrocytes increased in the
steady state above the total serum concentration. In
consequence, the ratio CE/CS rose from 0.72 to 1.21.
The digoxin concentration in unstimulated saliva was
also higher than the serum level in the steady state.
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Fig. 3. The digoxin concentration in serum, erythrocytes and
saliva
a) 12 hours after the intake of a single dose (0.5 mg)
and
b) 12 hours after the last intake of the drug in the
steady state (0.5 mg at 10 days).
Mean values of 6 male probands and one woman with
Standard deviations.
c$ = concentration in serum,
€ = free concentration in serum (ultrafiltrate),
CSSA = concentration in stimulated saliva,
CSA = concentration in unstimulated saliva,
CE = concentration in erythrocytes,
fb = fraction of serum protein bound drug (total mi-
nus free divided by total concentration).
The digoxin concentrations in serum water (free frac-
tion) and in stimulated saliva are similar in the pre-
steady state äs well äs in the steady state. The serum
fraction of bound digoxin also significantly rose from
0.28 to 0.42 (t-test, p < 0.05).
The experiment was repeated with 3 probands, using
a higher first dose of 1.0 mg digoxin to exclude any
influence of the total serum concentration on the
observed ratios. The mean ratio CE/CS was again 0.69
in the pre-steady state and 1.42 in the steady state,
and the mean CSA/CS 0.81 and 1.43, whereas the mean
C&A/CS ratio decreased slightly from 0.63 to 0.57
(fig-4).
If digoxin was applied for several days, the protein
binding capacity of serum was significantly increased,
and an even greater increase occurred in the intra-
celhilar binding and in the ratio of the unstimulated
to stimulated saliva concentration of the drug.
Discussion
Digoxin is a non-ionised, neutral and relatively lipo-
philic substance. Therefore, it should easily diffuse
from the blood compartment into saliva, independ-
ently of variations in the the pH-gradient. Mahmod
et al. (9) have pointed out that digoxin appears in
saliva at its maximum level within l nainute of intra-
venous injection. Joubert (12) has observed that con-
tamination can occur and recommended that mixed
saliva should be collected just prior to oral adminis-
tf ation of the next digoxin dosage. With this precau-
tion, the sälivary digoxin concentration should reflect
the free (non^protein bound) fraction of plasma or
serum digoxin, äs has been postulated for several
drugs which freely diffuse from the blood into saliva.
In accordance with this hypothesis, the digoxin con-
centration in stimulated saliva was close to the free
serum concentration. For other drugs Wood et al. (17)
have also assumed that increased flow rate tends to
restore the sälivary concentration towards the free
unbound plasma concentration of the drag.
Jusko (3) noticed that Stimulation of the sälivary flow
rate by chewing on Parafilm plates reduces the vari-
ability of the saliva/plasma distribution ratio, but it
also causes a slight reduction of the saliva eoncentra-
tion of digoxin, an öbservation confirmed by pur
present results.
Burgen (18) reported an inverse fünction of the secre-
tion rate and the sälivary concentration of methena-
mine arid several other substances. He pointed out
that penetration through the resting membrane occurs
J. Clin. Ghem. Clin. Biochem. / Vol. 27,1989 / No. 9
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Fig. 4. The dioxin concentration in serum, erythrocytes and saliva
a) 12 hours after the intake of a single dose (0.5 mg, lower part of the columns, and 1.0 mg, whole columns) and
b) 12 hours after the last intake of the drug in the steady state (0.5 mg at 10 days).
Column l is from a woman (48 years), column 2 and 3 are from male probands (50 and 26 years).
es = concentration in serum,
Cu = free concentration in serum (ultrafiltrate),
CSSA = concentration in stimulated saliva,
£SA = concentration in unstimulated saliva,
CE = concentration in erythrocytes
fb = fraction of serum protein bound drug (total minus free divided by total concentration).
largely through the membrane lipid, but the increase
in permeability e, g. with nerve Stimulation is largely
due to opening of watei>filled pores in the membrane.
If the decrease of the drug concentration could be
explained by a simple dilution effect, then the osmol-
ality should have shown a siinilar decrease.
In unstimulated saliva the digoxin concentration did
not correlate with the total or with the free serum
concentration, but with the concentration in the eryth-
roeytes.
It is well known that digoxin is concentrated in muscle
and other tissues including erythrocytes (14). The
concentration in erythrocytes is often used äs an easily
accessible indicatof fof the concentration in muscle
cells. .The large Volume pf distribütion (3-10 l/kg) is
ä further proof for the significant binding of digoxin
to tissues (14, 19). Lazowski et al. (10) have also
suggested an accuinulation in salivary glands.
Therefore, it could be that unstimulated saliva reflects
the intraceltular digoxin concentration and stimulated
saliva the free digoxin concentration in plasma.
Whether an active process accounts for the difference
between unstimulated and stimulated saliva, äs pos-
tulated for the kidney (20, 21), is not known. It is
also unclear whether the total erythrocyte digoxin
concentration represents that to which the digoxin
receptors in body are exposed, äs already assumed by
Krivoy et al. (8).
In conclusion, salivary digoxin arises from 2 compo-
nents: a diffusion component which approximates to
the free digoxin level in serum, and a second com-
ponent which exchanges slowly with the cellular com-
partment and may reflect the intracellular concentra-
tion. The latter concentration may parallel the phar-
macologically relevant fraction, but this needs further
clarificatiön.
The saliva/serum ratio of the digoxin concentration
varies with transition from a single dose to the steady
state and with the increase of the salivary flow rate.
Both effects have to be taken in account when inter-
preting the saliva/serum ratio and they may explain
the conflicting results in the literature.
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